Clinical Trial Imaging Market Growth, Trends, Size, Revenue, Scope, Challenges and Future Outlook

Clinical Trial Imaging Market Size- By Product & Services, By Modality, By Therapeutic area, By End-User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Clinical Trial Imaging Market Size- By Product & Services, By Modality, By Therapeutic area, By End-User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Published: Jul 2023 Report ID: HLCA2351 Pages: 1 - 229 Formats*:     
Category : Healthcare
Global Clinical Trial Imaging Market Introduction and Overview 

According to SPER Market Research, the Global Clinical Trial Imaging Market is estimated to reach USD 2.37 billion by 2033 with a CAGR of 7.83%.

The report includes an in-depth analysis of the Global Clinical Trial Imaging Market, including market size and trends, product mix, distribution channels, and supplier analysis. A clinical trial is a procedure for creating, studying, and assessing the effects of innovative medications. Before the introduction, extensive clinical testing is conducted to find promising molecules and determine any potential dangers. Companies that offer imaging services including image acquisition, analysis, and management are included in the clinical trial imaging market, as are businesses that create and produce imaging hardware and software for clinical trials.

  • Strict Regulatory Policies: The healthcare sector is governed by a complex and broad system of laws, rules, and regulations. The quality of imaging data produced in clinical trials is covered by the U.S. FDA's revised Guidance for Clinical Trial Imaging Endpoint Process Standards, which was published for the industry in April 2018.
  • Advancements in medical imaging technology: The continuous advancements in medical imaging technology have expanded the capabilities of imaging modalities such as magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), and ultrasound. These advancements allow for more precise and accurate imaging, enabling researchers to obtain detailed images for better analysis and evaluation in clinical trials.
Clinical Trial Imaging Market
Market Opportunities and Challenges
One important market opportunity for the global clinical trial imaging market is the increasing demand for personalized medicine and targeted therapies. As the understanding of diseases at the molecular level advances, there is a growing need to assess treatment efficacy and patient response using imaging techniques. Clinical trial imaging can play a crucial role in evaluating the effectiveness of targeted therapies by providing insights into drug distribution, target engagement, and treatment response. This presents an opportunity for the clinical trial imaging market to support the development and approval of personalized medicines.

However, a significant challenge in the global clinical trial imaging market is the complexity of integrating imaging data with other types of clinical data. Integrating imaging data with molecular, genomic, and clinical data from various sources requires robust data management and interoperability solutions. The challenge lies in standardizing data formats, developing interoperable systems, and ensuring seamless integration across different platforms and data repositories. Overcoming this challenge is essential for maximizing the potential of clinical trial imaging and harnessing the full power of multi-modal data analysis for improved clinical decision-making and patient outcomes.

Clinical Trial Imaging Market


Market Competitive Landscape
The Clinical Trial Imaging market is characterized by moderate competition, with multiple players operating in the industry. To maintain market share and diversify their product offerings, these big firms are implementing growth tactics such as new product launches, mergers, and acquisitions. The key players in the global Clinical Trial Imaging market include anagram 4 clinical trials, BioTelemetry (a Philips Company), Calyx, Clario, ICON plc, Image Core Lab, Invicro.LLC, IXICO plc, Koninklijke Philips N.V., Median Technologies, Navitas Life Sciences, Paraxel International Corporation, Perspectum, Quotient Sciences, Radiant Sage LLC, Resonance Health Analytical Services, WIRB-Copernicus Group, WORLDCARE CLINICAL, Others.

Scope of the Report:
 Report Metric Details
 Market size available for years 2019-2033
 Base year considered 2022
 Forecast period 2023-2033
 Segments coveredBy Product & Services, By Modality, By Therapeutic area, By End-User
 Regions coveredAsia-Pacific, Europe, Middle East and Africa, North America, Latin America
 Companies Coveredanagram 4 clinical trials, BioTelemetry (a Philips Company), Calyx, Clario, ICON plc, Image Core Lab, Invicro.LLC, IXICO plc, Koninklijke Philips N.V., Median Technologies, Navitas Life Sciences, Paraxel International Corporation, Perspectum, Quotient Sciences, Radiant Sage LLC, Resonance Health Analytical Services, WIRB-Copernicus Group, WORLDCARE CLINICAL, Others
COVID-19 Impact on Global Clinical Trial Imaging Market
The COVID-19 pandemic caused significant disruptions to clinical trials worldwide, leading to a decrease in the number of trials being conducted and impacting the demand for clinical trial imaging services. Lockdowns, travel restrictions, and fear of exposure to the virus resulted in reduced patient enrolment, affecting the availability of participants for imaging studies. Regulatory processes faced delays, causing challenges in obtaining approvals and hindering trial progress. To mitigate the impact, there was an increased focus on remote monitoring, allowing for remote collection and analysis of imaging data, reducing the need for in-person visits and imaging assessments.

Key Target Audience:
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Academic and Research Institutions
  • Clinical Research Associates (CRAs) and Investigators
  • Regulatory Authorities
  • Imaging Core Laboratories
  • Imaging Equipment and Software Providers
  • Investors and Venture Capital Firms
  • Regulatory Consultants and Legal Professionals
  • Healthcare Providers
Our in-depth analysis of the  Clinical Trial Imaging Market includes the following segments:
By Product & Services:
  • Imaging Software
  • Operational Imaging Services
  • Project & Data Management Services
  • Read Analysis Services
  • System and Technical Support Services
  • Trial Design & Consulting Services
  • By Modality:
  • Computed Tomography
  • Echocardiography
  • Magnetic Resonance Imaging
  • Nuclear Medicine
  • Optical Coherence Tomography
  • Positron Emission Tomography
  • Ultrasound
  • X-ray
  • Other Modalities
  • By Therapeutic area:
  • Oncology
  • Infectious Diseases
  • Neurology
  • CVS
  • Endocrinology
  • Immunological Disorder
  • Dermatology
  • Haematology
  • Gastroenterology
  • Other Therapeutic Area
  • By End-User:
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Medical Device Manufacturer
  • Contract Research Organizations
  • Other End-Users
  • Key Topics Covered in the Report:
    • Global Clinical Trial Imaging Market Size (FY’2023-FY’2033)
    • Description of Global Clinical Trial Imaging Market
    • Segmentation of Global Clinical Trial Imaging Market By Product & Services (Imaging Software, Operational Imaging Services, Project & Data Management Services, Read Analysis Services, System and Technical Support Services, Trial Design & Consulting Services)
    • Segmentation of Global Clinical Trial Imaging Market By Modality (Computed Tomography, Echocardiography, Magnetic Resonance Imaging, Nuclear Medicine, Optical Coherence Tomography, Positron Emission Tomography, Ultrasound, X-ray, Other Modalities)
    • Segmentation of Global Clinical Trial Imaging Market By Therapeutic area (Oncology, Infectious Diseases, Neurology, CVS, Endocrinology, Immunological Disorder, Dermatology, Haematology, Gastroenterology, Other Therapeutic Area)
    • Segmentation of Global Clinical Trial Imaging Market By End-User (Pharmaceutical Companies, Biotechnology Companies, Medical Device Manufacturer, Contract Research Organizations, Other End-Users)
    • Statistical Snap of Global Clinical Trial Imaging Market
    • Expansion Analysis of Global Clinical Trial Imaging Market
    • Problems and Obstacles in Global Clinical Trial Imaging Market
    • Competitive Landscape in the Global Clinical Trial Imaging Market
    • Impact of COVID-19 and Demonetization on Global Clinical Trial Imaging Market
    • Details on Current Investment in Global Clinical Trial Imaging Market
    • Competitive Analysis of Global Clinical Trial Imaging Market
    • Prominent Players in the Global Clinical Trial Imaging Market
    • SWOT Analysis of Global Clinical Trial Imaging Market
    • Global Clinical Trial Imaging Market Future Outlook and Projections (FY’2023-FY’2033)
    • Recommendations from Analyst
    1. Introduction
    1.1. Scope of the report
    1.2. Market segment analysis

    2. Research Methodology
    2.1. Research data source
    2.1.1. Secondary Data
    2.1.2. Primary Data
    2.1.3. SPER’s internal database
    2.1.4. Premium insight from KOL’s
    2.2. Market size estimation
    2.2.1. Top-down and Bottom-up approach
    2.3. Data triangulation

    3. Executive Summary

    4. Market Dynamics
    4.1. Driver, Restraint, Opportunity and Challenges analysis
    4.1.1. Drivers
    4.1.2. Restraints
    4.1.3. Opportunities
    4.1.4. Challenges
    4.2. COVID-19 Impacts of the Global Clinical Trial Imaging Market

    5. Market variable and outlook
    5.1. SWOT Analysis
    5.1.1. Strengths
    5.1.2. Weaknesses
    5.1.3. Opportunities
    5.1.4. Threats
    5.2. PESTEL Analysis
    5.2.1. Political Landscape
    5.2.2. Economic Landscape
    5.2.3. Social Landscape
    5.2.4. Technological Landscape
    5.2.5. Environmental Landscape
    5.2.6. Legal Landscape
    5.3. PORTER’s Five Forces 
    5.3.1. Bargaining power of suppliers
    5.3.2. Bargaining power of buyers
    5.3.3. Threat of Substitute
    5.3.4. Threat of new entrant
    5.3.5. Competitive rivalry
    5.4. Heat Map Analysis

    6. Competitive Landscape
    6.1. Global Clinical Trial Imaging Market Manufacturing Base Distribution, Sales Area, Product Type 
    6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Clinical Trial Imaging Market

    7. Global Clinical Trial Imaging Market, By Product & Services (USD Million)
    7.1. Global Clinical Trial Imaging Market Value Share and Forecast, By Product & Services, 2023-2033
    7.2. Imaging Software
    7.3. Operational Imaging Services
    7.4. Project & Data Management Services
    7.5. Read Analysis Services
    7.6. System and Technical Support Services
    7.7. Trial Design & Consulting Services

    8. Global Clinical Trial Imaging Market, By Modality (USD Million)
    8.1. Global Clinical Trial Imaging Market Value Share and Forecast, By Modality, 2023-2033
    8.2. Computed Tomography
    8.3. Echocardiography
    8.4. Magnetic Resonance Imaging
    8.5. Nuclear Medicine
    8.6. Optical Coherence Tomography
    8.7. Positron Emission Tomography
    8.8. Ultrasound
    8.9. X-ray
    8.10. Other Modalities

    9. Global Clinical Trial Imaging Market, By Therapeutic area (USD Million)
    9.1. Global Clinical Trial Imaging Market Value Share and Forecast, By Therapeutic area, 2023-2033
    9.2. Oncology
    9.3. Infectious Diseases
    9.4. Neurology
    9.5. CVS
    9.6. Endocrinology
    9.7. Immunological Disorder
    9.8. Dermatology
    9.9. Haematology
    9.10. Gastroenterology
    9.11. Other Therapeutic Area

    10. Global Clinical Trial Imaging Market, By End-User (USD Million)
    10.1. Global Clinical Trial Imaging Market Value Share and Forecast, By End-User, 2023-2033
    10.2. Pharmaceutical Companies
    10.3. Biotechnology Companies
    10.4. Medical Device Manufacturer
    10.5. Contract Research Organizations
    10.6. Other End-Users

    11. Global Clinical Trial Imaging Market Forecast, 2019-2033 (USD Million)
    11.1. Global Clinical Trial Imaging Market Size and Market Share

    12. Global Clinical Trial Imaging Market, By Product & Services, 2019-2033 (USD Million)
    12.1. Global Clinical Trial Imaging Market Size and Market Share By Product & Services (2019-2026)
    12.2. Global Clinical Trial Imaging Market Size and Market Share By Product & Services (2027-2033)

    13. Global Clinical Trial Imaging Market, By Modality, 2019-2033 (USD Million)
    13.1. Global Clinical Trial Imaging Market Size and Market Share By Modality (2019-2026)
    13.2. Global Clinical Trial Imaging Market Size and Market Share By Modality (2027-2033)

    14. Global Clinical Trial Imaging Market, By Therapeutic area, 2019-2033 (USD Million)
    14.1. Global Clinical Trial Imaging Market Size and Market Share By Therapeutic area (2019-2026)
    14.2. Global Clinical Trial Imaging Market Size and Market Share By Therapeutic area (2027-2033)

    15. Global Clinical Trial Imaging Market, By End-User, 2019-2033 (USD Million)
    15.1. Global Clinical Trial Imaging Market Size and Market Share By End-User (2019-2026)
    15.2. Global Clinical Trial Imaging Market Size and Market Share By End-User (2027-2033)

    16. Global Clinical Trial Imaging Market, By Region, 2019-2033 (USD Million)
    16.1. Global Clinical Trial Imaging Market Size and Market Share By Region (2019-2026)
    16.2. Global Clinical Trial Imaging Market Size and Market Share By Region (2027-2033)
    16.3. Asia-Pacific
    16.3.1. Australia
    16.3.2. China
    16.3.3. India
    16.3.4. Japan
    16.3.5. South Korea
    16.3.6. Rest of Asia-Pacific
    16.4. Europe
    16.4.1. France
    16.4.2. Germany
    16.4.3. Italy
    16.4.4. Spain
    16.4.5. United Kingdom
    16.4.6. Rest of Europe
    16.5. Middle East and Africa
    16.5.1. Kingdom of Saudi Arabia 
    16.5.2. United Arab Emirates
    16.5.3. Rest of Middle East & Africa
    16.6. North America
    16.6.1. Canada
    16.6.2. Mexico
    16.6.3. United States
    16.7. Latin America
    16.7.1. Argentina
    16.7.2. Brazil
    16.7.3. Rest of Latin America

    17. Company Profile
    17.1. anagram 4 clinical trials
    17.1.1. Company details
    17.1.2. Financial outlook
    17.1.3. Product summary 
    17.1.4. Recent developments
    17.2. BioTelemetry 
    17.2.1. Company details
    17.2.2. Financial outlook
    17.2.3. Product summary 
    17.2.4. Recent developments
    17.3. Calyx
    17.3.1. Company details
    17.3.2. Financial outlook
    17.3.3. Product summary 
    17.3.4. Recent developments
    17.4. Clario
    17.4.1. Company details
    17.4.2. Financial outlook
    17.4.3. Product summary 
    17.4.4. Recent developments
    17.5. ICON plc
    17.5.1. Company details
    17.5.2. Financial outlook
    17.5.3. Product summary 
    17.5.4. Recent developments
    17.6. Image Core Lab
    17.6.1. Company details
    17.6.2. Financial outlook
    17.6.3. Product summary 
    17.6.4. Recent developments
    17.7. Invicro LLC
    17.7.1. Company details
    17.7.2. Financial outlook
    17.7.3. Product summary 
    17.7.4. Recent developments
    17.8. IXICO plc
    17.8.1. Company details
    17.8.2. Financial outlook
    17.8.3. Product summary 
    17.8.4. Recent developments
    17.9. Koninklijke Philips N.V.
    17.9.1. Company details
    17.9.2. Financial outlook
    17.9.3. Product summary 
    17.9.4. Recent developments
    17.10. Median Technologies
    17.10.1. Company details
    17.10.2. Financial outlook
    17.10.3. Product summary 
    17.10.4. Recent developments
    17.11. Navitas Life Sciences
    17.11.1. Company details
    17.11.2. Financial outlook
    17.11.3. Product summary 
    17.11.4. Recent developments
    17.12. Paraxel International Corporation
    17.12.1. Company details
    17.12.2. Financial outlook
    17.12.3. Product summary 
    17.12.4. Recent developments
    17.13. Perspectum
    17.13.1. Company details
    17.13.2. Financial outlook
    17.13.3. Product summary 
    17.13.4. Recent developments
    17.14. Quotient Sciences
    17.14.1. Company details
    17.14.2. Financial outlook
    17.14.3. Product summary 
    17.14.4. Recent developments
    17.15. Radiant Sage LLC
    17.15.1. Company details
    17.15.2. Financial outlook
    17.15.3. Product summary 
    17.15.4. Recent developments
    17.16. Resonance Health Analytical Services
    17.16.1. Company details
    17.16.2. Financial outlook
    17.16.3. Product summary 
    17.16.4. Recent developments
    17.17. WIRB-Copernicus Group
    17.17.1. Company details
    17.17.2. Financial outlook
    17.17.3. Product summary 
    17.17.4. Recent developments
    17.18. WORLDCARE CLINICAL
    17.18.1. Company details
    17.18.2. Financial outlook
    17.18.3. Product summary 
    17.18.4. Recent developments
    17.19. Others
     
    18. List of Abbreviations

    19. Reference Links

    20. Conclusion

    21. Research Scope

    SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.

    The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings.  The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.

    SPER-Methodology-1

    SPER-Methodology-2

    SPER-Methodology-3


    Frequently Asked Questions About This Report
    Clinical Trial Imaging Market is projected to reach USD 2.37 billion by 2033, growing at a CAGR of 7.83% during the forecast period.
    Clinical Trial Imaging Market grew in market size from 2023. The Market is expected to reach USD 2.37 billion by 2033, at a CAGR of 7.83% during the forecast period.
    Clinical Trial Imaging Market CAGR of 7.83% during the forecast period.
    You can get the sample pages by clicking the link -Click Here
    The North America region is anticipated to have the highest market share in Clinical Trial Imaging Market.
    The key players in the market include Companies Covered anagram 4 clinical trials, BioTelemetry (a Philips Company), Calyx, Clario, ICON plc, Image Core Lab, Invicro.LLC, IXICO plc, Koninklijke Philips N.V., Median Technologies, Navitas Life Sciences, Paraxel International Corporation, Perspectum, Quotient Sciences, Radiant Sage LLC, Resonance Health Analytical Services, WIRB-Copernicus Group, WORLDCARE CLINICAL, Others
    A clinical trial is a procedure for creating, studying, and assessing the effects of innovative medications.
    Clinical Trial Imaging Market size is USD 2.37 billion from 2023 to 2033.
    Clinical Trial Imaging Market Segment is Covered By Product & Services, By Modality, By Therapeutic area, By End-User
    Not able to find what you are looking for? Need customization in the existing report?
    Click Here
    PLACE AN ORDER
    • 15% off
       
      $ 4250
    • 20% off
               
      $ 5650
    • 25% off
           
      $ 7450
    Pre-Purchase Inquiry
    SEND AN INQUIRY
    NEED CUSTOMIZATION?
    Request Customization
    CALL OR EMAIL US
    US:
    India:
    Email:
    100% Secure Payment

    SPER American Express
    SPER VISA
    SPER Master Card
    SPER Mestro
    SPER Paypal
    SPER CCAvenues

    Join Our SPER Panel

    Our Global Clients

    Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
    SPER-Astellas Pharma
    SPER-Citi Bank
    SPER-Microsoft
    SPER-EY
    SPER-McKinsey
    SPER-Bain
    SPER-Max-Healthcare
    SPER-DHL
    SPER-SIEMENS
    SPER-IQVIA
    SPER-Pfizer
    SPER-LOREAL
    SPER-Kankar IMRB
    SPER-ITA
    SPER-PWC
    SPER-Sanofi
    SPER-p&g
    SPER-Johnson & Johnson
    SPER-IPSOS
    SPER-Heineken

    SPER

    Market Research

    We are the leading, full-service global market research and consulting company.

    Certificates
    iso-1 iso-1 iso-1 ESOMAR
    Secure Payments
    SPER Payment Options
    Contact HR

     [email protected]

     +91-742-898-5650